系统性炎症与中风后认知轨迹之间的关联
Heidi Vihovde Sandvig1,2, Ingvild Saltvedt3,4, Trine Holt Edwin5
1Department of Medicine, Kristiansund Hospital, Sjukehuset Nordmøre og Romsdal, Møre og Romsdal Hospital Trust, Kristiansund, Norway. Heidi.V.Sandvig@ntnu.no.
Scientific reports
|November 29, 2025
概括
在中风后的急性阶段,炎症标志物的较高水平与更糟糕的认知轨迹和认知功能下降有关. 这些发现强调了系统性炎症在中风后认知障碍中的作用.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 老年学是一门学科.
背景情况:
- 认知障碍是中风的一个常见而严重的后果.
- 了解影响中风后认知轨迹的因素对于开发有针对性的干预措施至关重要.
- 系统性炎症越来越多地被认为是导致中风相关的大脑损伤和认知能力下降的潜在因素.
研究的目的:
- 研究血炎症生物标志物和相关代谢物在急性阶段和中风后3个月与不同认知轨迹之间的关联.
- 确定这些生物标志物和代谢物是否与中风后的时间内认知功能变化有关.
主要方法:
- 一项前性,多中心的队列研究 (中风后挪威认知障碍 - Nor-COAST) 涉及466名参与者.
- 使用蒙特利尔认知评估 (MoCA) 成绩建模的认知轨迹.
- 多项逻辑回归和混合线性回归用于分析生物标志物和认知结果之间的关联,按中风前的认知状态分层.
主要成果:
- 终端补充复合体的急性阶段水平较高,互白素6,巨细胞炎症蛋白1α,新素,氨酸和PA比率与低和下降的MoCA得分的风险较高有关.
- 较高的3个月内波特林水平也与更糟糕的认知轨迹有关.
- 增加的急性期瘤亡因子和互白素8与MoCA得分的逐渐下降有关.
- 脑卒中前的脆弱性显著影响了模型,混了一些关联.
结论:
- 在中风后的急性阶段,系统性炎症的升高与更糟糕的认知轨迹和衰退有关.
- 这些炎症标志物可能反映出身体对急性中风,并发症或先前存在的疾病的反应.
- 病前因素,特别是脆弱性,在中风后的认知结果中起着重要作用.
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
368
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
368
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
440
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
440
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296


